Related Experiment Video
Updated: Oct 20, 2025

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
Published on: January 30, 2014
Gα13 Contributes to LPS-Induced Morphological Alterations and Affects Migration of Microglia
Barbara Bettegazzi1,2, Serena Bellani3, Stefano Cattaneo3,4
1IRCCS San Raffaele Scientific Institute, via Olgettina 60, 20132, Milan, Italy. bettegazzi.barbara@hsr.it.
Abstract:
Microglia are the resident immune cells of the CNS that are activated in response to a variety of stimuli. This phenotypical change is aimed to maintain the local homeostasis, also by containing the insults and repair the damages. All these processes are tightly regulated and coordinated and a failure in restoring homeostasis by microglia can result in the development of neuroinflammation that can facilitate the progression of pathological conditions. Indeed, chronic microglia activation is commonly recognized as a hallmark of many neurological disorders, especially at an early stage. Many complex pathways, including cytoskeletal remodeling, are involved in the control of the microglial phenotypical and morphological changes that occur during activation. In this work, we focused on the small GTPase Gα13 and its role at the crossroad between RhoA and Rac1 signaling when microglia is exposed to pro-inflammatory stimulation. We propose the direct involvement of Gα13 in the cytoskeletal rearrangements mediated by FAK, LIMK/cofilin, and Rac1 during microglia activation. In fact, we show that Gα13 knockdown significantly inhibited LPS-induced microglial cell activation, in terms of both changes in morphology and migration, through the modulation of FAK and one of its downstream effectors, Rac1. In conclusion, we propose Gα13 as a critical factor in the regulation of morphological and functional properties of microglia during activation, which might become a target of intervention for the control of microglia inflammation.
Insights
Small GTPase Gα13 regulates microglial activation by influencing cytoskeletal changes. Inhibiting Gα13 reduces neuroinflammation, suggesting it as a therapeutic target for neurological disorders.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Microglia, the CNS immune cells, activate to maintain homeostasis but can cause neuroinflammation if dysregulated.
- Chronic microglia activation is a hallmark of neurological disorders, involving complex pathways like cytoskeletal remodeling.
- The small GTPase Gα13's role in microglia activation, particularly its interaction with RhoA and Rac1 signaling, is under investigation.
Purpose of the Study:
- To investigate the role of small GTPase Gα13 in microglia activation and cytoskeletal rearrangements.
- To elucidate the involvement of Gα13 in the FAK, LIMK/cofilin, and Rac1 signaling pathways during pro-inflammatory stimulation.
Main Methods:
- Utilized Gα13 knockdown to assess its impact on microglia activation.
- Examined changes in cell morphology and migration following LPS stimulation.
- Analyzed the modulation of FAK and Rac1 signaling pathways.
Main Results:
- Gα13 knockdown significantly inhibited LPS-induced microglial activation, affecting morphology and migration.
- Gα13 modulates FAK and its downstream effector Rac1 during microglia activation.
- Evidence suggests Gα13 is involved in cytoskeletal rearrangements mediated by FAK, LIMK/cofilin, and Rac1.
Conclusions:
- Gα13 is a critical regulator of microglial morphological and functional properties during activation.
- Gα13 plays a key role in cytoskeletal rearrangements essential for microglia response.
- Gα13 emerges as a potential therapeutic target for controlling neuroinflammation in neurological disorders.
More Related Videos
10:40Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain
Published on: October 27, 2019
07:27Two-photon Imaging of Microglial Processes' Attraction Toward ATP or Serotonin in Acute Brain Slices
Published on: January 31, 2019